Evidence map›Paper›PMID 29267390›Full record

ArticlePLoS pathogens2017

Association of Marek's Disease induced immunosuppression with activation of a novel regulatory T cells in chickens.

Angila Gurung, Nitin Kamble, Benedikt B Kaufer, Ansar Pathan, Shahriar Behboudi

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Frontiers in immunology · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. CD4Frontiers in immunology · 2023
    Article
  16. Article
  17. Article
  18. Article
  19. Frontiers in immunology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Angila GurungThe Pirbright Institute, Ash Road, Woking, United Kingdom.ORCID 0000-0001-7817-2505
Nitin KambleThe Pirbright Institute, Ash Road, Woking, United Kingdom.ORCID 0000-0003-1442-3293
Benedikt B KauferInstitut für Virologie, Freie Universität Berlin, Robert-von-Ostertag-Straße, Berlin, Germany.ORCID 0000-0003-1328-2695
Ansar PathanCollege of Health and Life Sciences, Department of Life Sciences, Brunel University, London, United Kingdom.ORCID 0000-0002-5759-3420
Shahriar BehboudiThe Pirbright Institute, Ash Road, Woking, United Kingdom.ORCID 0000-0001-6455-4086
The Pirbright Institute · GBBrunel University of London · GBFreie Universität Berlin · DE

Funding

Biotechnology and Biological Sciences Research Council BBS/E/I/00007031Biotechnology and Biological Sciences Research Council BBS/E/I/00007037Biotechnology and Biological Sciences Research Council BBS/E/I/00007038
6 · The paper itself

Abstract

Marek's Disease Virus (MDV) is an alphaherpesvirus that infects chickens, transforms CD4+ T cells and causes deadly lymphomas. In addition, MDV induces immunosuppression early during infection by inducing cell death of the infected lymphocytes, and potentially due to activation of regulatory T (Treg)-cells. Furthermore, immunosuppression also occurs during the transformation phase of the disease; however, it is still unknown how the disease can suppress immune response prior or after lymphoma formation. Here, we demonstrated that chicken TGF-beta+ Treg cells are found in different lymphoid tissues, with the highest levels found in the gut-associated lymphoid tissue (cecal tonsil: CT), fostering an immune-privileged microenvironment exerted by TGF-beta. Surprisingly, significantly higher frequencies of TGF-beta+ Treg cells are found in the spleens of MDV-susceptible chicken lines compared to the resistant line, suggesting an association between TGF-beta+ Treg cells and host susceptibility to lymphoma formation. Experimental infection with a virulent MDV elevated the levels of TGF-beta+ Treg cells in the lungs as early as 4 days post infection, and during the transformation phase of the disease in the spleens. In contrast to TGF-beta+ Treg cells, the levels of CD4+CD25+ T cells remained unchanged during the infection and transformation phase of the disease. Furthermore, our results demonstrate that the induction of TGF-beta+ Treg cells is associated with pathogenesis of the disease, as the vaccine strain of MDV did not induce TGF-beta+ Treg cells. Similar to human haematopoietic malignant cells, MDV-induced lymphoma cells expressed high levels of TGF-beta but very low levels of TGF-beta receptor I and II genes. The results confirm that COX-2/ PGE2 pathway is involved in immunosuppression induced by MDV-lymphoma cells. Taken together, our results revealed a novel TGF-beta+ Treg subset in chickens that is activated during MDV infection and tumour formation.

Indexed as

AnimalsCell Transformation, ViralChickensImmune ToleranceLymphocyte ActivationMarek DiseaseT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsTransforming Growth Factor betaTransforming Growth Factor beta

Identifiers

PMID29267390
PMCPMC5739506
OpenAlexW2779725955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.